return to results page

VAERS ID: 2156173

AGE: 15| SEX: F|State: FR

Description

Disease recurrence; Asthmatic crisis; Fatigue; Headache; Nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from the Regulatory Authority-WEB. Regulatory number: FR-AFSSAPS-BR20220331 (RA). A 15 year-old female patient received bnt162b2 (COMIRNATY), intramuscular, administration date 02Feb2022 14:00 (Batch/Lot number: unknown) at the age of 15 years as dose 2,single for covid-19 immunisation. Relevant medical history included: "Allergy to animal dander" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Mite allergy" (unspecified if ongoing); "Grass allergy" (unspecified if ongoing); "depression" (unspecified if ongoing). Concomitant medication(s) included: CETIRIZINE; FLUTIFORM; SPIRIVA; VENLAFAXINE. Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for Covid-19 immunisation. The following information was reported: DISEASE RECURRENCE (medically significant) with onset 02Feb2022 18:00, outcome "recovering", described as "Disease recurrence"; ASTHMATIC CRISIS (medically significant) with onset 02Feb2022 18:00, outcome "recovering", described as "Asthmatic crisis"; FATIGUE (non-serious) with onset 02Feb2022 16:00, outcome "recovered", described as "Fatigue"; HEADACHE (non-serious) with onset 02Feb2022 16:00, outcome "recovered", described as "Headache"; NAUSEA (non-serious) with onset 02Feb2022 16:00, outcome "recovered", described as "Nausea". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (02Feb2022) negative. Therapeutic measures were taken as a result of disease recurrence, asthmatic crisis. Clinical course: 4 hours after the injection around 6 p.m., an asthma attack. Improvement under Ventolin 15 puffs twice at 20 minute intervals then 4 puffs in the evening at bedtime and upon waking. Immediate implementation of the asthma attack protocol, namely 15 puffs of Ventolin. Again 15 puffs of Ventolin 20 minutes later, then improvement. 4 puffs of Ventolin before going to bed and again 4 on waking. Rapid improvement in the attack following the implementation of the usual asthma attack management protocol. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Symptoms

Asthmatic crisis, SARS-CoV-2 test, Disease recurrence, Fatigue, Headache, Nausea

Vaccines

VAX DATE: 01 February 2022 | ONSET DATE: 01 February 2022 | DAYS TO ONSET: 0
Vaccine TypeManufacturerVaccine NameDoseRouteSiteLot
  • COVID19
  • PFIZERBIONTECH
  • COVID19 (COVID19 (PFIZER-BIONTECH))
  • 2
  • OT

RECVDATE:03 March 2022
CAGE_YR:
CAGE_MO:
RPT_DATE:
DIED:
DATEDIED:
L_THREAT:
ER_VISIT:
HOSPITAL:
HOSPDAYS:
X_STAY:
DISABLE:
RECOVD:N
LAB_DATA:Test Date: 20220202; Test Name: SARS-CoV-2 test; Test Result: Negative
V_ADMINBY:OTH
OTHER_MEDS:CETIRIZINE; FLUTIFORM; SPIRIVA; VENLAFAXINE
CUR_ILL:
HISTORY:Medical History/Concurrent Conditions: Allergy to animal dander; Asthma; Depression; Grass allergy; Mite allergy
PRIOR_VAX:
SPLTTYPE:FRPFIZER INC202200293921
FORM_VERS:2
TODAYS_DATE:01 March 2022
BIRTH_DEFECT:
OFC_VISIT:
ER_ED_VISIT:
ALLERGIES:
V_FUNDBY:
return to results page

Questions? Comments? Bugs?
[email protected]
Due to the high volume of inquiries, please be patient with response times.

AND PLEASE read the FAQ first.

OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.